Floatz logo

Therapeutic Asset Ratings

4,361 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Cyclophosphamide
High Grade B-Cell Lymphoma With MYC And/ Or BCL2 And/Or BCL6 Rearrangement
National Cancer Institute (NCI)P3BB (66)
Cyclophosphamide
Gastric Neoplasm
National Cancer Institute (NCI)P3BB (66)
Cytosin-Arabinosid
T-Cell Adult Acute Lymphocytic Leukemia
National Cancer Institute (NCI)P3BB (66)
DACARBAZINE
Hodgkin'S Lymphoma, Mixed Cellularity
National Cancer Institute (NCI)P3BB (66)
DACARBAZINE
Nodular Sclerosis Classical Hodgkin Lymphoma
National Cancer Institute (NCI)P3BB (66)
DACARBAZINE
Hodgkin'S Lymphoma, Lymphocytic Depletion
National Cancer Institute (NCI)P3BB (66)
DACARBAZINE
Hodgkin'S Lymphoma, Lymphocytic-Histiocytic Predominance
National Cancer Institute (NCI)P3BB (66)
DEXAMETHASONE
Down Syndrome
National Cancer Institute (NCI)P3BB (66)
Docetaxel
Metastatic Castration Resistant Prostate Cancer
National Cancer Institute (NCI)P3BB (66)
Docetaxel
Prostate Cancer
National Cancer Institute (NCI)P3BB (66)
Eloxatin
Ovarian Mucinous Cystadenocarcinoma
National Cancer Institute (NCI)P3BB (66)
Fludarabine
Acute Myeloid Leukemia With Multilineage Dysplasia
National Cancer Institute (NCI)P3BB (66)
Fludarabine
Hematopoietic And Lymphoid Cell Neoplasm
National Cancer Institute (NCI)P3BB (66)
FLUDEOXYGLUCOSE
Hodgkins Lymphoma
National Cancer Institute (NCI)P3BB (66)
FLUOROURACILUM
HIV Infectious Disease
National Cancer Institute (NCI)P3BB (66)
Hycamtin
Fallopian Tube Serous Adenocarcinoma
National Cancer Institute (NCI)P3BB (66)
Ifosfamide
Classic Hodgkin Lymphoma
National Cancer Institute (NCI)P3BB (66)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
High Grade B-Cell Lymphoma With MYC And/ Or BCL2 And/Or BCL6 Rearrangement
National Cancer Institute (NCI)P3BB (66)
Inno-206
Fallopian Tube Clear Cell Adenocarcinoma
National Cancer Institute (NCI)P3BB (66)
Inno-206
High Grade B-Cell Lymphoma With MYC And/ Or BCL2 And/Or BCL6 Rearrangement
National Cancer Institute (NCI)P3BB (66)
Inno-206
Hodgkin'S Lymphoma, Lymphocytic-Histiocytic Predominance
National Cancer Institute (NCI)P3BB (66)
Inno-206
T-Cell Childhood Acute Lymphocytic Leukemia
National Cancer Institute (NCI)P3BB (66)
INTERFERON ALFA-2B
Metastatic Melanoma
National Cancer Institute (NCI)P3BB (66)
Irinotecan
Borderline Ovarian Mucinous Tumor
National Cancer Institute (NCI)P3BB (66)
Irinotecan
Ovarian Mucinous Cystadenocarcinoma
National Cancer Institute (NCI)P3BB (66)
Showing 301 to 325 of 4,361 assets
PreviousPage 13 of 175Next